Lauren Nye

846 total citations
37 papers, 369 citations indexed

About

Lauren Nye is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lauren Nye has authored 37 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lauren Nye's work include Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Genomics and Diagnostics (8 papers). Lauren Nye is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Genomics and Diagnostics (8 papers). Lauren Nye collaborates with scholars based in United States, Australia and Belgium. Lauren Nye's co-authors include Anne O’Dea, Qamar J. Khan, Priyanka Sharma, William J. Gradishar, Kelsey E. Larson, Jamie L. Wagner, Christa Balanoff, Andrew K. Godwin, Rachel Yoder and Joshua M. Staley and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Lauren Nye

30 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lauren Nye United States	9	270	115	76	58	46	37	369
Takuho Okamura Japan	10	207 0.8×	96 0.8×	70 0.9×	42 0.7×	72 1.6×	30	331
Carla Strina Italy	10	242 0.9×	125 1.1×	71 0.9×	107 1.8×	24 0.5×	25	362
Monica Barbolini Italy	9	254 0.9×	117 1.0×	96 1.3×	127 2.2×	28 0.6×	26	399
Eriseld Krasniqi Italy	10	197 0.7×	99 0.9×	95 1.3×	93 1.6×	59 1.3×	21	342
Valentina Magri Italy	11	207 0.8×	132 1.1×	63 0.8×	66 1.1×	20 0.4×	28	345
Guzmán Alonso Spain	8	177 0.7×	75 0.7×	161 2.1×	66 1.1×	43 0.9×	34	313
Yiwei Tong China	12	169 0.6×	138 1.2×	51 0.7×	72 1.2×	23 0.5×	33	302
Roberto Piciotti Italy	9	128 0.5×	76 0.7×	50 0.7×	86 1.5×	15 0.3×	15	317
Xi-Chun Hu China	9	112 0.4×	117 1.0×	71 0.9×	112 1.9×	31 0.7×	12	318
Binyi Xiao China	13	226 0.8×	82 0.7×	70 0.9×	125 2.2×	46 1.0×	37	391

Countries citing papers authored by Lauren Nye

Since Specialization

Citations

This map shows the geographic impact of Lauren Nye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Nye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Nye more than expected).

Fields of papers citing papers by Lauren Nye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Nye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Nye. The network helps show where Lauren Nye may publish in the future.

Co-authorship network of co-authors of Lauren Nye

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Nye. A scholar is included among the top collaborators of Lauren Nye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Nye. Lauren Nye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stecklein, Shane R., Roberto Salgado, Julia White, et al.. (2025). Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 124(3). 717–725.

Wagner, Jamie L., et al.. (2025). Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes. Annals of Surgical Oncology. 32(11). 8411–8420.

Lad, Neha L., et al.. (2025). Abstract P1-10-10: Outcomes of Abemaciclib Dose Escalation Strategy in High-Risk Early Breast Cancer. Clinical Cancer Research. 31(12_Supplement). P1–10.

Nye, Lauren, Angela Williams, Dinesh Pal Mudaranthakam, et al.. (2024). Using catchment area data to guide a breast cancer health equity task force efforts in the heartland. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations

Stecklein, Shane R., Roberto Salgado, Anne O’Dea, et al.. (2024). NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 42(16_suppl). TPS629–TPS629. 3 indexed citations

Parkinson, Gary N., Mark Lustberg, Seyed Saeed Hashemi Nazari, et al.. (2024). 342MO Metastatic hormone receptor-positive breast cancer outcomes in 628 patients with BRCA1, BRCA2, or PALB2 pathogenic variants: Real-world data analysis of genomics and targeted therapy sequencing. Annals of Oncology. 35. S358–S358.

Larson, Kelsey E., Christa Balanoff, Lauren Nye, et al.. (2023). Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare. 11(3). 417–417. 4 indexed citations

Stecklein, Shane R., Bruce F. Kimler, Rachel Yoder, et al.. (2023). ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. npj Breast Cancer. 9(1). 10–10. 16 indexed citations

Stecklein, Shane R., Devin C. Koestler, Nanda Kumar Yellapu, et al.. (2023). Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD).. Journal of Clinical Oncology. 41(16_suppl). 578–578. 3 indexed citations

10.

Sharma, Priyanka, Shane R. Stecklein, Rachel Yoder, et al.. (2023). Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials. Cancer Research. 83(5_Supplement). PD11–7. 2 indexed citations

11.

Larson, Kelsey E., et al.. (2022). Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all. The American Journal of Surgery. 225(1). 21–25. 3 indexed citations

12.

Sharma, Priyanka, Shane R. Stecklein, Rachel Yoder, et al.. (2022). Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).. Journal of Clinical Oncology. 40(16_suppl). 513–513. 37 indexed citations

13.

Nye, Lauren, Anne O’Dea, Priyanka Sharma, et al.. (2020). Incorporating of telementoring (Project ECHO) into practice: Efficacy of Point Of Service Testing-Breast Cancer (ePOST-BC).. Journal of Clinical Oncology. 38(29_suppl). 113–113.

14.

Fabian, Carol J., Lauren Nye, Teresa A. Phillips, et al.. (2019). Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study. Cancer Prevention Research. 12(10). 711–720. 30 indexed citations

15.

Amin, Amanda L., Christa Balanoff, Kelsey E. Larson, et al.. (2018). Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions. Annals of Surgical Oncology. 25(10). 2948–2952. 62 indexed citations

16.

Nye, Lauren, Alfred Rademaker, & William J. Gradishar. (2017). Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era. Clinical Breast Cancer. 17(4). e185–e189. 15 indexed citations

17.

Santa‐Maria, Cesar A., et al.. (2016). Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?. PubMed. 30(2). 148–55. 33 indexed citations

18.

Agulnik, Mark, Ricardo Costa, Mohammed Milhem, et al.. (2016). A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas. Annals of Oncology. 28(1). 121–127. 23 indexed citations

19.

Agulnik, Mark, Mohammed Milhem, Alfred Rademaker, et al.. (2015). A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas.. Journal of Clinical Oncology. 33(15_suppl). 10515–10515. 2 indexed citations

20.

Nye, Lauren, et al.. (2012). Diagnostic and Treatment Considerations When Newly Diagnosed Breast Cancer Coincides With Pregnancy: A Case Report and Review of Literature. Journal of the National Comprehensive Cancer Network. 10(2). 145–148. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact